...
首页> 外文期刊>Contraception >Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users
【24h】

Weight and body fat changes in postpartum depot-medroxyprogesterone acetate users

机译:产后长效醋酸甲羟孕酮使用者的体重和体脂变化

获取原文
获取原文并翻译 | 示例

摘要

Background: Although postpartum depot-medroxyprogesterone acetate (DMPA) recipients often cite weight gain as the reason for discontinuing DMPA, little is known about body composition changes in postpartum DMPA recipients. Study design: Women who used DMPA during the postpartum year were measured on several anthropometric dimensions of body composition and compared with women who elected surgical sterilization with bilateral partial salpingectomy (BPS). Results: After 1 year, DMPA recipients did not differ from the BPS group in weight or percent body fat changes. Almost half the women using DMPA returned to pregravid weight; nearly half gained weight. Higher pre-pregnancy body mass index was associated with weight gain among DMPA recipients. Conclusions: DMPA recipients who were overweight or obese before pregnancy may have greater risk for weight gain in the first year postpartum. However, when counseling women, the risk for DMPA-related weight gain should be balanced against the potential for increased weight from subsequent pregnancies.
机译:背景:尽管产后长效醋酸甲羟孕酮(DMPA)接受者经常将体重增加作为停用DMPA的原因,但对产后DMPA接受者的身体成分变化知之甚少。研究设计:在产后一年中使用DMPA的妇女在人体测量的几个维度上进行了测量,并与选择采用双侧部分输卵管切除术(BPS)进行手术绝育的妇女进行了比较。结果:1年后,DMPA接受者与BPS组在体重或体脂变化百分比上没有差异。几乎有一半使用DMPA的妇女恢复了前重。近一半体重增加。 DMPA接受者中较高的孕前体重指数与体重增加相关。结论:妊娠前超重或肥胖的DMPA接受者在产后第一年体重增加的风险可能更大。但是,在为女性提供咨询时,应权衡与DMPA相关的体重增加的风险与随后怀孕导致体重增加的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号